24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Oxford PharmaGenesis is proud to sponsor the latest clinical trials education campaign spearheaded by CISCRP (The Center for Information and Study on Clinical Research Participation) and aimed at building awareness of clinical trials among minority communities in the USA.
A career in medical communications means you can look forward to an exciting and rewarding future. As a leading, independent, award-winning company, Oxford PharmaGenesis is growing fast – and we’re looking for top talent to grow with us.
Members of the Oxford PharmaGenesis team in Melbourne recently attended the 2021 Asia Pacific (APAC) meeting of the International Society for Medical Publication Professionals (ISMPP), a virtual event held on 9 and 10 September 2021. Oxford PharmaGenesis was a proud Ruby Sponsor of this stimulating meeting, which showcased the latest advances in scientific communications and…
Oxford PharmaGenesis won big at the PMLiVE Communiqué Awards 2021 on Wednesday 1 September, winning in two categories entered: Medical affairs agency of the year and Excellence in global education meetings/stand-alone events.
Oxford PharmaGenesis is proud to sponsor a dedicated supplement in USA Today, helping raise awareness of clinical trials. The June 2021 supplement aims to increase the visibility and public understanding of clinical trials, and help patients to prepare and navigate the clinical trials process. Oxford PharmaGenesis stands alongside several global pharmaceutical companies in supporting this…
A new, dedicated Informatics and Data Science Practice is poised to optimize data insights for Oxford PharmaGenesis clients. The practice builds on more than 20 years of in-house experience, and will take advantage of the growing and evolving volume of biomedical data sources within healthcare.
